ADR's of Edap TMS (EDAP +17.8%) jump today on the back of a postitive article in Seeking Alpha,...

|About: EDAP TMS S.A. (EDAP)|By:, SA News Editor

ADR's of Edap TMS (EDAP +17.8%) jump today on the back of a postitive article in Seeking Alpha, calling it the 'holy grail' in the fight against prostate cancer. Its recent disclosure of test data on its Ablatherm-HIFU - which uses High-Intensity Focused Ultrasound to eviscerate localized prostate cancer - shows it's testing progress has advanced well beyond the stage of laboratories and mice, and is highly likely to receive FDA approval.